HomeOwner SearchCategory Search
Visit USCOThe Journal of Pharmacology and Experimental Therapeutics [Published: 2021-01-27. Issue: vol. 376, no. 2, February 2021]
Serial Registration
Copyright Title
The Journal of Pharmacology and Experimental Therapeutics [Published: 2021-01-27. Issue: vol. 376, no. 2, February 2021]
Status
Published
on 27 Jan 2021
Year of Creation
2021
Copyright Claimant
American Society for Pharmacology and Experimental Therapeutics
Registration Number
TX0008948244
on 27 Jan 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008948244) dated 27 Jan 2021, pertains to an electronic file (eService) titled "The Journal of Pharmacology and Experimental Therapeutics [Published: 2021-01-27. Issue: vol. 376, no. 2, February 2021]" created in 2021. The copyright holder is American Society for Pharmacology and Experimental Therapeutics, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to American Society for Pharmacology and Experimental Therapeutics.
Application Details
Registration Number
TX0008948244
Registration Date
1/27/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
American Society for Pharmacology and Experimental Therapeutics
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISSN
1521-0103
Notes
Rights Note: American Society for Pharmacology and Experimental Therapeutics, 1801 Rockville Pike, Suite 201, Rockville, MD, 20852-1633, United States, (301) 634-7060, journals@aspet.org
Copyright Local Holdings: vol. 376, no. 2, February 2021 Created 2021 Pub. 2021-01-27 Reg. 2021-01-27 TX0008948244 MKEITH
Statements
Application Title Statement: The Journal of Pharmacology and Experimental Therapeutics
Author Statement: American Society for Pharmacology and Experimental Therapeutics employer for hire Domicile: United States Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.